Skip to main content

Table 3 Effects of CCl4, MpEO and their combination MpEO/CCl4 on hepatic markers in serum of control and experimental rats

From: Protective effects of Mentha piperita L. leaf essential oil against CCl4 induced hepatic oxidative damage and renal failure in rats

Treatment and parameters

AST (U/L)

ALT (U/L)

ALP (U/L)

LDH (U/L)

γ-GT (U/L)

Control

164.82 ± 1.28

65.88 ± 1.44

149.61 ± 2.19

20.81 ± 0.52

3.17 ± 0.39

CCl4

524.12 ± 5.11***

179.23 ± 3.39***

217.47 ± 8.55***

40.66 ± 0.81***

5.43 ± 0.21***

SL/CCl4

191.15 ± 2.14###

87.82 ± 7.61###

157.50 ± 5.12##

28.62 ± 0.62###

3.47 ± 0.06###

MpEOa/CCl4

479.89 ± 36.41

162.02 ± 9.18

202.42 ± 7.62

37.75 ± 1.35

4.45 ± 0.25

MpEOb/CCl4

356.82 ± 35.77##

147.35 ± 5.67##

186.74 ± 3.98#

34.16 ± 1.35##

4.06 ± 0.17##

MpEOc/CCl4

216.80 ± 7.26###

97.82 ± 6.98###

165.96 ± 5.12###

31.64 ± 5.12###

3.51 ± 0.20###

MpEOc

160.80 ± 2.47

63.08 ± 1.16

139.77 ± 7.27

19.89 ± 0.18

2.81 ± 0.24

  1. AST aspartate aminotransferase, ALT alanine aminotransferase, ALP alkaline phosphatase, LDH lacatate dehydrogenase and γGT gamma glutamyl transferase.aMpEO(5 mg/kg BW), bMpEO(15 mg/kg BW), cMpEO(40 mg/kg BW), SL: Silymarin (50 mg/kg BW)
  2. Values are mean ± SEM for eight rats in each group. CCl4, MpEO and MpEO/CCl4 treated groups vs control group; ** p < 0.01, *** p < 0.001, CCl4 group vs MpEO/CCl4 group; # p < 0.05, # # p < 0.01, # # # p < 0.001